Web Summary
Q1: What is the company name and its location?
A1: The company name is MSD Animal Health Vietnam Co., Ltd., but it seems that this information is not explicitly mentioned in the provided text. However, based on the copyright notice at the end of the page, it is stated that "We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ USA". This suggests that MSD Animal Health Vietnam Co., Ltd. might be a subsidiary or branch office of Merck & Co., Inc.
Q2: What products does the company offer?
A2: The provided text mentions several products offered by MSD Animal Health, including BRAVECTO (fluralaner) for dogs, which offers unparalleled duration of flea and tick protection compared to existing products. Additionally, it mentions NOBILIS MULTRIVA, a product that has received a positive CVMP opinion.
Q3: What industry does the company operate in?
A3: MSD Animal Health operates in the animal health industry, specifically focusing on companion animals, equine, swine, poultry, ruminate, and aquaculture.
Q4: What services does the company provide?
A4: The company provides various services, including product quality and safety assessments, animal health and welfare policies and positions, careers, and contact information for media inquiries.
Q5: Who is Laurie Hueneke Martens and what award did she receive?
A5: Laurie Hueneke Martens is an associate vice president of Global Public Policy and Government Relations at MSD Animal Health. She received the "Feather in Her Cap" Award for Contributions to the Animal Health Industry from the Feather in Her Cap Association.
Q6: What is the company's commitment to sustainability and responsibility?
A6: The company is committed to focusing on sustainability, investing in tomorrow’s veterinarians and associated professionals, and preserving and improving the health, well-being, and performance of animals through science.
Q7: How did S&P Global Animal Health award BRAVECTO (fluralaner)?
A7: S&P Global Animal Health awarded the injectable formulation of BRAVECTO (fluralaner) the 2024 Best New Companion Animal Product for its unparalleled duration of flea and tick protection compared to existing products.
Q8: What is the company's approach to innovation?
A8: The company fosters innovation through its team of scientists and researchers, who are committed to advancing the state of veterinary medicine and developing new technologies and solutions to improve animal health.